Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-06-16

Dendritic Cells in the Pathogenesis of Atherosclerosis

Obiettivo

Atherosclerosis is the main cause of death in the industrial world. The understanding of the pathogenesis has led to the notion of atherosclerosis as a chronic inflammatory disease. The evidence of a network of vascular-associated dendritic cells (DC) in arteries of healthy young individuals, as well as findings demonstrating an infiltration of atherosclerotic plaques where DC accumulation in close contact with macrophages/ monocytes and T-cells implies an important role of DC suggests a functional role of DC, in the activation of the vascular immune system and in the pathogenesis of atherosclerosis. So far the molecular mechanisms regulating the recruitment and causative role of DC in the formation of atherosclerotic plaques remains to be elucidated. DC derives from hematopoietic cells but also peripheral monocytes. So far, several different markers have been used to detect DC in atherosclerotic lesions, however, these are of low specificity.

The CCL17 chemokine (also referred to as dendrokine) is expressed only by mature DC. Using an eGFP knock-in, CCL17 knock-out, crossed into the atherosclerosis prone apolipoprotein E deficient (apoE-/-) background, will allow us to specifically study the role of DC in pathological pathways operative in atherosclerosis. The infiltration and localization of DC in atherosclerotic lesions will be studied by detection of GFP-expressing DC in heterozygous CCL17E/+ apoE-/- mice by dual photon microscopy. Double knockout mice will be used to evaluate the role of DC and of their effector chemokines CCL17 in lesion development in native atherosclerosis. Furthermore, in vitro and in vivo assays will be performed to investigate the instruction or modulation of a specific immune response during the initiation and progression of atherosclerotic lesions.

Campo scientifico (EuroSciVoc)

Argomento(i)

Invito a presentare proposte

FP6-2005-MOBILITY-5
Vedi altri progetti per questo bando

Meccanismo di finanziamento

EIF - Marie Curie actions-Intra-European Fellowships

Coordinatore

CARDIOVASCULAR RESEARCH INSTITUTE MAASTRICHT
Contributo UE
Nessun dato
Costo totale
Nessun dato